Oncologic outcomes in myxofibrosarcomas: the role of a multidisciplinary approach and surgical resection margins

ANZ J Surg. 2023 Mar;93(3):577-584. doi: 10.1111/ans.18320. Epub 2023 Feb 11.

Abstract

Backgrounds: Myxofibrosarcomas (MFS) are malignant soft tissue sarcomas with an infiltrative growth pattern and propensity for local recurrence(LR).We aimed to assess our management of MFS and make recommendations about the role of a multidisciplinary team approach and margin widths.

Methods: Fifty-seven patients were identified with MFS treated at a single sarcoma centre between 1998 and 2020. Patients were stratified based on whether they presented for a planned resection (59.6%) or after an unplanned resection (40.4%) performed at a non-specialized facility. All patients underwent radiotherapy before definitive surgery.

Results: 73.7% underwent a combined onco-plastic approach. The 5 year LRFS rate was 78.2% (84.4%, planned, versus 70.1%, unplanned, P = 0.194) and found comparable oncological outcomes between the planned and unplanned groups for the 5 year metastasis free survival (74.5% versus 86.1%, P = 0.257), disease free survival (70.1% versus 72.4%, P = 0.677), and Overall Survival (64.5% versus 75.9%, P = 0.950). Margin width ≥ 2 cm was obtained in 84.2% of cases and improved local control (HR = 0.22; 95% CI 0.06-0.81; P = 0.023), metastasis (HR = 0.24; 95% CI 0.07-0.80; P = 0.019) and mortality rates (HR = 0.23; 95% CI 0.09, 0.61; P = 0.003) compared to <2 cm. Margin width > 3 cm did not further affect oncological outcomes.

Conclusion: Our study shows that a multidisciplinary team approach allows the achievement of low local recurrence rate and good oncological outcomes of myxofibrosarcomas, regardless of presentation status. We recommend a minimum of 2 cm margin width.

Keywords: Margin width; Multidisciplinary; Myxofibrosarcoma; oncological outcomes; sarcoma.

MeSH terms

  • Adult
  • Fibrosarcoma* / pathology
  • Fibrosarcoma* / secondary
  • Fibrosarcoma* / therapy
  • Histiocytoma, Malignant Fibrous*
  • Humans
  • Margins of Excision
  • Neoplasm Recurrence, Local / pathology
  • Progression-Free Survival
  • Retrospective Studies
  • Sarcoma* / surgery
  • Soft Tissue Neoplasms* / surgery